Level C· Early human research exploring benefitsCase Report / SeriesEurope PMCOpen access

Use of Liquid Platelet-Rich Fibrin (Liquid PRF) as a New, Effective Regenerative Treatment for Steroid-Induced Subcutaneous and Dermal Atrophy

Aalami Harandi S., Saadat S., Miron RJ., Farshidfar N., Balighi K.

Case Report / Series on Shoulder Pain, published in Cureus (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Cureus (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42326147
PMCID
PMC13280524
DOI
10.7759/cureus.109245

Abstract (original English)

Subcutaneous and dermal atrophy are known complications of corticosteroid injections. Due to aesthetic and/or functional concerns, such as fat loss, visible depressions, skin thinning, and discoloration of the affected area, an effective treatment modality for reconstructing the area remains needed. Considering the regenerative properties of platelet-rich fibrin (PRF), its potential in soft tissue repair, and its efficacy in aesthetics, we used this natural autologous biomaterial to treat steroid-induced dermal and subcutaneous atrophy in our patient. A 35-year-old woman developed a well-defined atrophic area measuring approximately 3 × 7 cm² in the scapular region following a triamcinolone injection for shoulder pain. The area was characterized by a pronounced depression with irregular indented borders, along with dermal thinning and dyspigmentation. Treatment included three sessions of liquid PRF injections at monthly intervals. Each PRF injection session resulted in progressive improvement in the depth and quality of the atrophic area. One month after the third session and at six-month follow-up, significant improvement with marked restoration was observed in subcutaneous tissue volume, skin texture, depigmentation, and overall aesthetic outcomes based on subjective clinical assessment. No adverse effects were observed during treatment and follow-ups. Liquid PRF may represen

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research